Key result
Left subclavian anode placement links to ~39% higher absolute defibrillation success vs superior vena cava.
Why the study?
Does placing the defibrillation anode in the left subclavian vein improve endovenous defibrillation success compared to the superior vena cava in patients undergoing ICD implantation?
Cohort (n=33)
Does placing the defibrillation anode in the left subclavian vein improve endovenous defibrillation success compared to the superior vena cava in patients undergoing ICD implantation?
Placing the second defibrillation lead in the left subclavian vein significantly improves endovenous defibrillation efficacy compared to the standard superior vena cava position.
Answers are grounded in this paper and cite their sources.
Left subclavian anode placement was associated with higher defibrillation success; leaves open need for randomized confirmation before practice change.
The optimal placement for the second defibrillation lead in a two-lead system has never been addressed. We retrospectively reviewed the data of 33 patients with an average age of 59.2 years (range 41-78 years), predominantly male (n = 29), who underwent implantation of a cardioverter defibrillator (ICD) for treatment of ventricular tachycardia (n = 19) or ventricular fibrillation (n = 14). In all patients an attempt was made to implant an endovenous ICD device (leads only, no subcutaneous patch). In group I (n = 18) the defibrillation anode, a separate unipolar lead, was placed in the common position, the superior vena cava. In group II (n = 15) the lead was placed in the left subclavian vein. At least two consecutive shocks reverting ventricular fibrillation at energies < or = 24 J were required for implantation of the ICD device. All shocks were monophasic. The success rate of endovenous defibrillation was significantly higher in group II than in group I (67% vs 28%, P < 0.05). Thus, it could be demonstrated that the position of the defibrillation anode can influence the defibrillation efficacy in transvenous ICD systems. Prospective randomized trials are needed to investigate the optimal position for the second defibrillation electrode, which may gain increasing importance as soon as dual chamber ICDs become available.
No takes yet. Share an insight, caveat, or question.
Markewitz et al. (1995) conducted a cohort in Ventricular tachycardia or ventricular fibrillation (n=33). Defibrillation anode placed in the left subclavian vein vs. Defibrillation anode placed in the superior vena cava was evaluated on Success rate of endovenous defibrillation (p=< 0.05). Placing the defibrillation anode in the left subclavian vein achieved a higher success rate of endovenous defibrillation compared to the superior vena cava.
Synapse has enriched 10 related papers. Consider them for comparative context: